Literature DB >> 18375534

Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosus.

G H Stummvoll1, R D Fritsch, B Meyer, E Hoefler, M Aringer, J S Smolen, G Steiner.   

Abstract

OBJECTIVE: To address key aspects of anti-histone autoimmunity in systemic lupus erythaematosus (SLE), we performed a detailed characterisation of cellular and humoral autoreactivity to histone H1 and the four core histones H2A, H2B, H3, H4 in patients with SLE and healthy controls.
METHODS: Peripheral blood mononuclear cells of 41 patients with SLE and 28 healthy controls were exposed to individual histones and proliferation was measured by [(3)H]-thymidine incorporation. H1-reactive T cell clones were obtained by limiting dilution. Cytokines and total IgG in culture supernatants was measured by ELISA, and autoantibodies to histones were determined by ELISA and immunoblotting.
RESULTS: Proliferative responses to H1 were more frequent and more pronounced in cell cultures from patients with SLE (p<0.002), while among the core histones only the response to H2A was increased in patient cultures (p<0.01). All histones elicited a Th1-like cytokine response in patients and controls (high interferon (IFN)gamma and tumour necrosis factor (TNF)alpha, no interleukin (IL)4) with H1 inducing the highest levels of TNFalpha. However, H1 stimulated production of IgG and anti-histone antibodies only in cell cultures derived from patients with SLE. H1-specific T cell clones from patients and controls showed a CD4+CD28+ phenotype and a Th1 cytokine profile. Anti-histone antibodies were detected in 51% of patients with SLE, were primarily directed to H1, H3 and H4, and predominantly of the IgG2 subtype.
CONCLUSIONS: Histone H1 constitutes a major B cell and T cell autoantigen in SLE, triggering a proinflammatory Th1 response and driving autoantibody production. This suggests that histone H1 may be of considerable relevance for the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375534     DOI: 10.1136/ard.2007.082032

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

1.  [Immunopathogenesis of systemic lupus erythematosus].

Authors:  Martin Aringer; Stephanie Finzel; Reinhard E Voll
Journal:  Z Rheumatol       Date:  2022-05-13       Impact factor: 1.372

Review 2.  Types of necroinflammation, the effect of cell death modalities on sterile inflammation.

Authors:  Anett Mázló; Viktória Jenei; Sára Burai; Tamás Molnár; Attila Bácsi; Gábor Koncz
Journal:  Cell Death Dis       Date:  2022-05-02       Impact factor: 9.685

3.  Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.

Authors:  Li Zhang; Anne M Bertucci; Rosalind Ramsey-Goldman; Elizabeth Randall Harsha-Strong; Richard K Burt; Syamal K Datta
Journal:  Clin Immunol       Date:  2013-08-23       Impact factor: 3.969

4.  Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling.

Authors:  Pamina Pflegerl; Paul Vesely; Brigitte Hantusch; Michaela Schlederer; Rainer Zenz; Elke Janig; Günter Steiner; Arabella Meixner; Peter Petzelbauer; Peter Wolf; Afschin Soleiman; Gerda Egger; Richard Moriggl; Tadamitsu Kishimoto; Erwin F Wagner; Lukas Kenner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

5.  Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease.

Authors:  Eva N Hadaschik; Xiaoying Wei; Harald Leiss; Britta Heckmann; Birgit Niederreiter; Günter Steiner; Walter Ulrich; Alexander H Enk; Josef S Smolen; Georg H Stummvoll
Journal:  Arthritis Res Ther       Date:  2015-02-23       Impact factor: 5.156

6.  Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis.

Authors:  Jürgen Dieker; Jo H Berden; Marinka Bakker; Jean-Paul Briand; Sylviane Muller; Reinhard Voll; Christopher Sjöwall; Martin Herrmann; Luuk B Hilbrands; Johan van der Vlag
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

7.  Systemic lupus erythematosus patients contain significantly less igm against mono-methylated lysine than healthy subjects.

Authors:  Sha Guo; Ying Liu; Younan Ma; Qing Zhao; Liping Zhu; Yuehu Shao; Fengying Gao; Fengqi Wu; Ruitong Gao; Wei Zhang
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.